Skip to main content

Table 2 Distribution of PN and its association with health status characteristics of the participants

From: Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda

   PN n (%) n = 507   
Variable No PN PN p-value All
CD4 cell count <=350 63 (51) 91 (49) 0.98 154 (30)
  >350 144 (41) 209 (59) 353 (70)
Duration since HIV diagnosis 0 – 3 years ago 72 (46) 84 (54) <0.001* 156 (31)
4 – 6 years ago 91 (49) 96 (51) 187 (37)
  7 and above yrs 44 (27) 120 (73) 164 (32)
Current ARV regimen Non d4T containing 156 (39) 247 (61) 0.056 403 (79)
d4T containing 51 (49) 53 (51) 104 (21)
Duration on ARVs (in years) 0 – 1 71 (58) 52 (42) <0.001* 123 (24)
1 – 3 58 (36) 101 (64) 159 (32)
4 – 6 61 (30) 108 (64) 169 (33)
7 and above 17 (41) 39 (70) 56 (11)
ARV regimen changes None 44 (43) 48 (57) 0.045 102 (20)
Once 120 (44) 150 (56) 270 (53)
  Two and more 43 (32) 92 (68) 135 (27)
ARV started with Non D4T containing 62 (37) 104 (63) 0.27 166 (33)
  D4T containing 145 (43) 196 (57) 341 (67)
  1. *Denotes significant association, n = number of participants.